Supriya Lifesci.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE07RO01027
  • NSEID: SUPRIYA
  • BSEID: 543434
INR
674.30
-10.45 (-1.53%)
BSENSE

Feb 20

BSE+NSE Vol: 53.57 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 7.61% vs 24.31% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -1.94% vs 67.38% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 1.67% vs 64.48% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 11.81% vs -15.89% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of Supriya Lifesci. With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
551.35
1,561.96
-1,010.61
-64.70%
Other Operating Income
0.00
0.00
0.00
Total Operating income
551.35
1,561.96
-1,010.61
-64.70%
Raw Material Cost
181.76
419.76
-238.00
-56.70%
Purchase of Finished goods
0.00
86.37
-86.37
-100.00%
(Increase) / Decrease In Stocks
-33.06
-7.31
-25.75
-352.26%
Employee Cost
71.86
368.67
-296.81
-80.51%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
134.36
467.21
-332.85
-71.24%
Total Expenditure (Excl Depreciation)
354.92
1,334.69
-979.77
-73.41%
Operating Profit (PBDIT) excl Other Income
196.43
227.27
-30.84
-13.57%
Other Income
8.01
77.13
-69.12
-89.61%
Operating Profit (PBDIT)
204.44
304.40
-99.96
-32.84%
Interest
1.42
3.43
-2.01
-58.60%
Exceptional Items
-0.46
-20.79
20.33
97.79%
Gross Profit (PBDT)
202.56
280.18
-77.62
-27.70%
Depreciation
19.91
44.79
-24.88
-55.55%
Profit Before Tax
182.65
235.40
-52.75
-22.41%
Tax
47.76
56.55
-8.79
-15.54%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
134.90
178.86
-43.96
-24.58%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
134.90
178.86
-43.96
-24.58%
Equity Capital
16.10
16.28
-0.18
-1.11%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
35.63%
14.55%
0.00
21.08%
Gross Profit Margin
36.74%
17.94%
0.00
18.80%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 551.35 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 7.61% vs 24.31% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 134.90 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -1.94% vs 67.38% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 196.43 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 1.67% vs 64.48% in Dec 2024

Nine Monthly - Interest
Interest 1.42 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 11.81% vs -15.89% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.63%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024